Browse > Article

Cloning and Expression of hpaA Gene of Korean Strain Helicobacter pylori K51 in Oral Vaccine Delivery Vehicle Lactococcus lactis subsp. lactis MG1363  

Kim Su-Jung (Laboratory of Immunobiology, Department of Microbiology, College of Natural Sciences, Kyungpook National University, Department of Clinical Pathology, Daegu Health College)
Jun Do-Youn (Institute of Genetic Engineering, Kyungpook National University)
Yang Chae-Ha (Department of Oriental Medicine, College of Oriental Medicine, Daegu Haany University)
Kim Young-Ho (Laboratory of Immunobiology, Department of Microbiology, College of Natural Sciences, Kyungpook National University)
Publication Information
Journal of Microbiology and Biotechnology / v.16, no.2, 2006 , pp. 318-324 More about this Journal
Abstract
In order to develop an oral vaccine to prevent H. pylori infection, we have expressed the hpaA gene of H. pylori K51 isolated from Korean patients, encoding 29-kDa HpaA that is known to be localized on the cell surface and flagella sheath, in a live delivery vector system, Lactococcus lactis. The hpaA gene, amplified by PCR using the genomic DNA of H. pylori K51, was cloned in the pGEX-2T vector, and the DNA sequence analysis revealed that the hpaA gene of H. pylori K51 had 99.7% and 94.8% identity with individual hpaA genes of the H. pylori 26695 strain (U.K) and the J99 strain (U.S.A). A polyclonal anti-HpaA antibody was raised in rats using GST-HpaA fusion protein as the antigen. The hpaA gene was inserted in an E. coli-L. lactis-shuttle vector (pMG36e) to express in L. lactis. Western blot analysis showed that the expression level of HpaA in the L. lactis transformant remained constant from the exponential phase to the stationary phase, without extracelluar secretion. These results indicate that the HpaA of H. pylori K51 was successfully expressed in L. lactis, and suggest that the recombinant L. lactis expressing HpaA may be applicable as an oral vaccine to induce a protective immune response against H. pylori.
Keywords
Helicobacter pylori; HpaA; rat polyclonal anti-HpaA; oral vaccine vehicle; Lactococcus lactis;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
Times Cited By Web Of Science : 5  (Related Records In Web of Science)
연도 인용수 순위
1 Alm, R. A., L. S. Ling, D. T. Moir, B. L. King, E. D. Brown, P. C. Doig, D. R. Smith, B. Noonan, B. C. Guild, B. L. deJonge, G. Carmel, P. J. Tummino, A. Caruso, M. Uria- Nickelsen, D. M. Mills, C. Ives, R. Gibson, D. Merberg, S. D. Mills, Q. Jiang, D. E. Taylor, G. F. Vovis, and T. J. Trust. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397: 176-180   DOI   ScienceOn
2 Blanchard, T. G., M. L. Drakes, and S. J. Czinn. 2004. Helicobacter infection: Pathogenesis. Curr. Opin. Gastroenterol. 20: 10-15   DOI   ScienceOn
3 Chen, M., J. Chen, W. Liao, S. Zhu, J. Yu, W. K. Leung, P. Hu, and J. J. Sung. 2003. Immunization with attenuated Salmonella typhimurium producing catalase in protection against gastric Helicobacter pylori infection in mice. Helicobacter 8: 613-625   DOI   ScienceOn
4 Crespo, A. and B. Suh. 2001. Helicobacter pylori infection: Epidemiology, pathophysiology, and therapy. Arch. Pharm. Res. 24: 485-498   DOI   ScienceOn
5 Jun, D. Y., S. W. Rue, B. W. Kim, and Y. H. Kim. 2003. Detection of mitotic centromere-associated kinesin (MCAK) during cell cycle progression of human Jurkat T cells using polyclonal antibody raised against its N-terminal region overexpressed in E. coli. J. Microbiol. Biotechnol. 13: 912- 918   과학기술학회마을
6 Pei, H., J. Liu, Y. Cheng, C. Sun, C. Wang, Y. Lu, J. Ding, J. Zhou, and H. Xiang. 2005. Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination. Appl. Microbiol. Biotechnol. [Epub ahead of print]
7 Steidler, L., W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, W. Fiers, and E. Remaut. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin- 10. Science 289: 1352-1355   DOI   ScienceOn
8 Xin, K.-Q, Y. Hoshino, Y. Toda, S. Igimi, Y. Kojima, N. Jounai, K. Ohba, A. Kushiro, M. Kiwaki, K. Hamajima, D. Klinman, and K. Okuda. 2003. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102: 223- 228   DOI   ScienceOn
9 Zendehdel, N., S. Nasseri-Moghaddam, R. Malekzadeh, S. Massarrat, M. Sotoudeh, and F. Siavoshi. 2005. Helicobacter pylori reinfection rate 3 years after successful eradication. J. Gastroenterol. Hepatol. 20: 401-404   DOI   ScienceOn
10 Bermudez-Humaran, L. G., P. Langella, A. Miyoshi, A. Gruss, R. T. Guerra, R. Montes de Oca-Luna, and Y. Le Loir. 2002. Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl. Environ. Microbiol. 68: 917-922   DOI
11 Prinz, C., N. Hafsi, and P. Voland. 2003. Helicobacter pylori virulence factors and the host immune response: Implications for therapeutic vaccination. Trends Microbiol. 11: 134-138   DOI   ScienceOn
12 Cheun, H. I., K. Kawamoto, M. Hiramatsu, H. Tamaoki, T. Shirahata, S. Igimi, and S. I. Makino. 2004. Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection. J. Appl. Microbiol. 96: 1347-1353   DOI   ScienceOn
13 Kitazawa, H., T. Itoh, Y. Tomioka, M. Mizugaki, and T. Yamaguchi. 1996. Induction of IFN-gamma and IL-1 alpha production in macrophages stimulated with phosphopolysaccharide produced by Lactococcus lactis ssp. cremoris. Int. J. Food Microbiol. 31: 99-106   DOI   ScienceOn
14 Nakayama, Y. and D. Y. Graham. 2004. Helicobacter pylori infection: Diagnosis and treatment. Expert. Rev. Anti. Infect. Ther. 2: 599-610   DOI   ScienceOn
15 Nouaile, S., L. A. Ribeiro, A. Miyoshi, D. Pontes, Y. L. Loir, S. C. Oliverira, P. Langella, and V. Azevedo. 2003. Heterologous protein production and delivery systems for Lactococcus lactis. Genet. Mol. Res. 2: 102-111
16 Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547   DOI   ScienceOn
17 Xu, C., Z. S. Li, Y. Q. Du, Z. X. Tu, Y. F. Gong, J. Jin, H. Y. Wu, and G. M. Xu. 2005. Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA. World J. Gastroenterol. 11: 114- 117   DOI
18 Evans, D. J. J. and D. G. Evans. 2000. Helicobacter pylori adhesins: Review and perspectives. Helicobacter 5: 183- 195   DOI   ScienceOn
19 Lee, M. H., Y. Roussel, M. Wiks, and S. Tabaqchali. 2001. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG 1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19: 3927-3935   DOI   ScienceOn
20 van de Guchte, M., J. M. van der Vossen, J. Kok, and G. Venema. 1989. Construction of a lactococcal expression vector: Expression of hen egg white lysozyme in Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 55: 224-228
21 Jun, D. Y., S. W. Rue, S. J. Kim, and Y. H. Kim. 2005. Differential intracellular localization of mitotic centromere-associated kinesin (MCAK) during cell cycle progression in human Jurkat T cells. Kor. J. Life Sci. 15: 253-260   과학기술학회마을   DOI
22 O'Toole, P. W., L. Janzon, P. Doig, J. Huang, M. Kostrzynska, and T. J. Trust. 1995. The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein. J. Bacteriol. 177: 6049-6057   DOI
23 Jones, A. C., R. P. H. Logan, S. Foynes, A. Cockayne, B. W. Wren, and C. W. Penn. 1997. A flagellar sheath protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose- banding hemagglutinin, but is not an adhesin for AGS cells. J. Bacteriol. 179: 5643-5647   DOI
24 Voland, P., N. Hafsi, M. Zeitner, S. Laforsch, H. Wagner, and C. Prinz. 2003. Antigenic properties of HpaA and Omp18, two outer membrane proteins of Helicobacter pylori. Infect. Immun. 71: 3837-3843   DOI
25 Kim, J. Y., S. Lee, S. Hachimura, S. Kaminogawa, and H. J. Lee. 2003. In vitro immunopotentiating activity of cellular components of Lactococcus lactis ssp. lactis. J. Microbiol. Biotechnol. 13: 202-206
26 Liu, X. L., S. Q. Li, C. J. Liu, H. X. Tao, and Z. S. Zhang. 2004. Antigen epitope of Helicobacter pylori vacuolating cytotoxin A. World J. Gastroenterol. 10: 2340-2343   DOI
27 Robinson, K., L. M. Chamberlain, M. C. Lopez, C. M. Rush, H. Marcotte, R. W. Le Page, and J. M. Wells. 2004. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect. Immun. 72: 2753-2761   DOI
28 Satin, B., G. Del Giudice, V. Della Bianca, S. Dusi, C. Laudanna, F. Tonello, D. Kelleher, R. Rappuoli, C. Montecucco, and F. Rossi. 2000. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 191: 1467-1476   DOI
29 Lundstrom, A. M., K. Blom, V. Sundaeus, and I. Bolin. 2001. HpaA shows variable surface localization but the gene expression is similar in different Helicobacter pylori strains. Microb. Pathog. 31: 243-253   DOI   ScienceOn
30 Lee, W.-K., S.-H. Choi, S.-G. Park, Y.-J. Choi, M.-Y. Choe, J.-W. Park, S.-A. Jung, E.-Y. Byun, J.-Y. Song, T.-S. Jung, B.-S. Lee, S.-C. Baik, M.-J. Cho, H.-S. Youn, G.-H. Ko, Y.- S. Kim, J.-H. Park, D.-S. Lee, H.-S. Yoo, S.-Y. Ghim, and K.-H. Lee. 1999. Genomic diversity of Helicobacter pylori. J. Kor. Soc. Microbiol. 34: 519-532   과학기술학회마을
31 Theisen, M., S. Soe, K. Brunstedt, F. Follmann, L. Bredmose, H. Israelsen, S. M. Madsen, and P. Druilhe. 2004. A Plasmodium falciparum GLURP-MSP3 chimeric protein; Expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies. Vaccine 22: 1188-1198   DOI   ScienceOn
32 Ribeiro, L. A., V. Azevedo, Y. Le Loir, S. C. Oliveira, Y. Dieye, J. C. Piard, A. Gruss, and P. Langella. 2002. Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: A first step towards food-grade live vaccines against brucellosis. Appl. Environ. Microbiol. 68: 910-916   DOI
33 Woo, J. S., B. H. Ha, T. G. Kim, Y. Lim, and K. H. Kim. 2003. Inhibition of Helicobacter pylori adhesion by acidic polysaccharide isolated from Artemisia capillaries. J. Microbol. Biotechnol. 13: 853-858   과학기술학회마을
34 Choi, K. M., J. K. Park, and S. Y. Hwang. 2003. Pathogenetic impact of vacuolar degeneration by accelerated transport of Helicobacter pylori VacA. J. Microbiol. Biotechnol. 13: 666-672
35 Holo, H. and I. F. Nes. 1989. High-frequency transformation by electroporation of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl. Environ. Microbiol. 55: 3119-3123